BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sumida K, Molnar MZ, Potukuchi PK, Hassan F, Thomas F, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Treatment of rheumatoid arthritis with biologic agents lowers the risk of incident chronic kidney disease. Kidney Int 2018;93:1207-16. [PMID: 29409725 DOI: 10.1016/j.kint.2017.11.025] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Lee SW. Risk Factors Associated with Estimated Glomerular Filtration Rate in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis after Treatment with Biological Disease Modifying Anti-Rheumatic Drugs. J Korean Med Sci 2018;33:e214. [PMID: 30034307 DOI: 10.3346/jkms.2018.33.e214] [Reference Citation Analysis]
2 Rodrigues JC, Bargman JM. Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation? Clin J Am Soc Nephrol 2018;13:679-80. [PMID: 29661771 DOI: 10.2215/CJN.03300318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Chang LH, Hwu CM, Chu CH, Lin YC, Huang CC, You JY, Chen HS, Lin LY. The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus. J Endocrinol Invest 2021. [PMID: 33834419 DOI: 10.1007/s40618-021-01568-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Zhang T, Liang S, Feng X, Li M, Zhou H, Zeng C, Zhang J, Cheng Z. Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement. Clin Exp Med 2020;20:191-7. [PMID: 32048072 DOI: 10.1007/s10238-019-00602-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Woodell T, Avasare RS. Nephrotoxicity of Select Rheumatologic Drugs. Rheumatic Disease Clinics of North America 2018;44:605-17. [DOI: 10.1016/j.rdc.2018.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Tsai MT, Tarng DC. Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients. Int J Mol Sci 2018;20:E117. [PMID: 30597982 DOI: 10.3390/ijms20010117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bandach I, Segev Y, Landau D. Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia. Sci Rep 2021;11:6288. [PMID: 33737665 DOI: 10.1038/s41598-021-85778-2] [Reference Citation Analysis]
8 Hanaoka H, Ishigaki S, Takei H, Hiramoto K, Saito S, Kondo Y, Kikuchi J, Kaneko Y, Takeuchi T. Early combination of pulmonary vasodilators prevents chronic kidney disease progression in connective tissue disease-associated pulmonary hypertension. Int J Rheum Dis 2021;24:1419-26. [PMID: 34626090 DOI: 10.1111/1756-185X.14225] [Reference Citation Analysis]
9 Kim SK, Choe JY. Gender Is a Risk Factor for Annual Decline in Estimated Glomerular Filtration Rate in Patients Treated with Biological DMARDs in Rheumatoid Arthritis and Ankylosing Spondylitis: a Retrospective Observational Study. J Korean Med Sci 2018;33:e188. [PMID: 30034303 DOI: 10.3346/jkms.2018.33.e188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
10 Hayashi K, Sada KE, Asano Y, Asano SH, Yamamura Y, Ohashi K, Morishita M, Watanabe H, Narazaki M, Matsumoto Y, Wada J. Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis. Sci Rep 2020;10:18715. [PMID: 33127957 DOI: 10.1038/s41598-020-75655-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wagan AA, Nasir S, Rahim A, Khan D. Impaired renal functions in Pakistani cohort of rheumatoid arthritis. Pak J Med Sci 2019;35:905-10. [PMID: 31372115 DOI: 10.12669/pjms.35.4.564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Grams ME, Surapaneni A, Chen J, Zhou L, Yu Z, Dutta D, Welling PA, Chatterjee N, Zhang J, Arking DE, Chen TK, Rebholz CM, Yu B, Schlosser P, Rhee EP, Ballantyne CM, Boerwinkle E, Lutsey PL, Mosley T, Feldman HI, Dubin RF, Ganz P, Lee H, Zheng Z, Coresh J. Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol 2021;32:2291-302. [PMID: 34465608 DOI: 10.1681/ASN.2020111607] [Reference Citation Analysis]
13 Nakashima A, Horita S, Matsunaga T, Inoue R, Zoshima T, Mizushima I, Hara S, Ito K, Fujii H, Nomura H, Kawano M. Factors contributing to discrepant estimated glomerular filtration values measured by creatinine and cystatin C in patients with rheumatoid arthritis. Sci Rep 2021;11:9884. [PMID: 33972623 DOI: 10.1038/s41598-021-89303-3] [Reference Citation Analysis]
14 Watson D, Yang JYC, Sarwal RD, Sigdel TK, Liberto JM, Damm I, Louie V, Sigdel S, Livingstone D, Soh K, Chakraborty A, Liang M, Lin PC, Sarwal MM. A Novel Multi-Biomarker Assay for Non-Invasive Quantitative Monitoring of Kidney Injury. J Clin Med 2019;8:E499. [PMID: 31013714 DOI: 10.3390/jcm8040499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
15 Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (N Y) 2020;1:90-102. [PMID: 33294881 DOI: 10.1016/j.medj.2020.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]